Sydney court grants injunction over herpes treatments

A New York pharma company has won an injunction to prevent its Australian partner from terminating their contract ahead of an ICC arbitration over services related to commercialising treatments for skin infections caused by herpes.


Get unlimited access to all Global Arbitration Review content